Your weekly strategic brief on the cyber threat landscape. Uncover the deeper patterns behind attacks, from bootkit malware ...

It has been reported that Novo Nordisk may have inadvertently allowed generics of its GLP-1 agonist semaglutide, the active ingredient in diabetes therapy Ozempic and ...